EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan

Impfschutz und unerwünschte Ereignisse nach einer reaktiven Impfkampagne gegen Hepatitis E im Binnenvertriebenenlager Bentiu, Südsudan

Robin C Nesbitt iD, Vincent Kinya Asilaza, Etienne Gignoux, Aybüke Koyuncu, Priscillah Gitahi, Patrick Nkemenang, Jetske Duncker, Zelie Antier, Melat Haile, Primitive Gakima, Joseph F Wamala, Fredrick Beden Loro und 5 weitere

PLOS Neglected Tropical Diseases · 22.01.2024 · 18 (1) · e0011661

DOI: 10.1371/journal.pntd.0011661 ↗

Auf einen Blick

Nach drei Impfkampagnen im Bentiu-Lager lag die Selbstangabe für mindestens 1 Dosis Hecolin bei 86 %. Schwere unerwünschte Ereignisse wurden nicht berichtet.

Fragestellung

Wie hoch waren Impfquote und unerwünschte Ereignisse nach einer reaktiven Impfkampagne gegen Hepatitis E im Bentiu-Lager?

Methode

Impfabdeckungssurvey nach der dritten Impfkampagne mit einfacher Zufallsstichprobe; passive AEFI-Überwachung an Impfstellen und Gesundheitseinrichtungen.

Ergebnisse

1.599 Personen wurden befragt. Selbstberichtete Abdeckung: 86 % mit mindestens 1 Dosis, 73 % mit mindestens 2 Dosen, 58 % mit 3 Dosen. 91/1.195 (7,6 %) berichteten neue Symptome innerhalb von 72 Stunden.

Schlussfolgerung der Autor:innen

Die Hecolin-Impfung erreichte nach drei Runden eine hohe Abdeckung mit mindestens 1 Dosis; schwere AEFI traten nicht auf. Die Impfung wurde gut akzeptiert und vertragen.

Kernaussagen

  • 86 % mit mindestens 1 Dosis, 73 % mit mindestens 2 Dosen, 58 % mit 3 Dosen
  • 91/1.195 (7,6 %) meldeten neue Symptome innerhalb von 72 Stunden
  • Keine schweren AEFI berichtet

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 22.01.2024. Verfasst von Robin C Nesbitt und 16 weiteren Autor:innen. Beteiligte Einrichtung: Epicentre, Paris, France. Hauptthemen laut MEDLINE: Refugees, Hepatitis E. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatitis E (HEV) genotypes 1 and 2 are the common cause of jaundice and acute viral hepatitis that can cause large-scale outbreaks. HEV infection is associated with adverse fetal outcomes and case fatality risks up to 31% among pregnant women. An efficacious three-dose recombinant vaccine (Hecolin) has been licensed in China since 2011 but until 2022, had not been used for outbreak response despite a 2015 WHO recommendation. The first ever mass vaccination campaign against hepatitis E in response to an outbreak was implemented in 2022 in Bentiu internally displaced persons camp in South Sudan targeting 27,000 residents 16–40 years old, including pregnant women.

Methods

We conducted a vaccination coverage survey using simple random sampling from a sampling frame of all camp shelters following the third round of vaccination. For survey participants vaccinated in the third round in October, we asked about the onset of symptoms experienced within 72 hours of vaccination. During each of the three vaccination rounds, passive surveillance of adverse events following immunisation (AEFI) was put in place at vaccination sites and health facilities in Bentiu IDP camp.

Results

We surveyed 1,599 individuals and found that self-reported coverage with one or more dose was 86% (95% CI 84–88%), 73% (95% CI 70–75%) with two or more doses and 58% (95% CI 55–61%) with three doses. Vaccination coverage did not differ significantly by sex or age group. We found no significant difference in coverage of at least one dose between pregnant and non-pregnant women, although coverage of at least two and three doses was 8 and 14 percentage points lower in pregnant women. The most common reasons for non-vaccination were temporary absence or unavailability, reported by 60% of unvaccinated people. Passive AEFI surveillance captured few mild AEFI, and through the survey we found that 91 (7.6%) of the 1,195 individuals reporting to have been vaccinated in October 2022 reported new symptoms starting within 72 hours after vaccination, most commonly fever, headache or fatigue.

Conclusions

We found a high coverage of at least one dose of the Hecolin vaccine following three rounds of vaccination, and no severe AEFI. The vaccine was well accepted and well tolerated in the Bentiu IDP camp community and should be considered for use in future outbreak response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RefugeesHepatitis EHumansFemalePregnancyAdolescentYoung AdultAdultVaccination CoverageSouth SudanVaccinationImmunization Programs

Autor:innen und Institutionen

  • Epicentre, Paris, France.
  • Médecins Sans Frontières, Juba, South Sudan.
  • Médecins Sans Frontières, Geneva, Switzerland.
  • Johns Hopkins University Bloomberg School of Public Health, Baltimore, United States of America.
  • World Health Organization, Juba, South Sudan.
  • Ministry of Health, Juba, South Sudan.

ORCID-Profile: Robin C Nesbitt

Förderung

  • World Health Organization

Zitieren

APA

Nesbitt, R. C., Asilaza, V. K., Gignoux, E., Koyuncu, A., Gitahi, P., Nkemenang, P., Duncker, J., Antier, Z., Haile, M., Gakima, P., Wamala, J. F., Loro, F. B., Biem, D., Rull, M., Azman, A. S., Rumunu, J., & Ciglenecki, I. (2024). Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan. PLOS Neglected Tropical Diseases, 18(1), e0011661. https://doi.org/10.1371/journal.pntd.0011661

Vancouver

Nesbitt RC, Asilaza VK, Gignoux E, Koyuncu A, Gitahi P, Nkemenang P, et al. Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan. PLOS Neglected Tropical Diseases. 2024;18(1):e0011661. doi:10.1371/journal.pntd.0011661

BibTeX
@article{Nesbitt2024,
  author = {Nesbitt, Robin C and Asilaza, Vincent Kinya and Gignoux, Etienne and Koyuncu, Aybüke and Gitahi, Priscillah and Nkemenang, Patrick and Duncker, Jetske and Antier, Zelie and Haile, Melat and Gakima, Primitive and Wamala, Joseph F and Loro, Fredrick Beden and Biem, Duol and Rull, Monica and Azman, Andrew S and Rumunu, John and Ciglenecki, Iza},
  title = {Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {1},
  pages = {e0011661},
  doi = {10.1371/journal.pntd.0011661}
}
Kostenlos starten →